142 related articles for article (PubMed ID: 27935327)
1. Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53.
Chhabra A; Mukherji B; Batra D
Expert Opin Ther Targets; 2017 Feb; 21(2):117-129. PubMed ID: 27935327
[TBL] [Abstract][Full Text] [Related]
2. Death receptor-independent activation-induced cell death in human melanoma antigen-specific MHC class I-restricted TCR-engineered CD4 T cells.
Chhabra A; Mukherji B
J Immunol; 2013 Sep; 191(6):3471-7. PubMed ID: 23935194
[TBL] [Abstract][Full Text] [Related]
3. Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy.
Mehrotra S; Chhabra A; Chattopadhyay S; Dorsky DI; Chakraborty NG; Mukherji B
J Immunol; 2004 Nov; 173(10):6017-24. PubMed ID: 15528336
[TBL] [Abstract][Full Text] [Related]
4. Activation-induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis-inducing factor.
Chhabra A; Mehrotra S; Chakraborty NG; Dorsky DI; Mukherji B
Eur J Immunol; 2006 Dec; 36(12):3167-74. PubMed ID: 17109472
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy.
Chhabra A
Vaccine; 2010 Jun; 28(29):4566-72. PubMed ID: 20451638
[TBL] [Abstract][Full Text] [Related]
6. Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cells.
Chhabra A; Mukherji B
Hum Immunol; 2016 Oct; 77(10):905-911. PubMed ID: 27320826
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death.
Mehrotra S; Chhabra A; Hegde U; Chakraborty NG; Mukherji B
J Leukoc Biol; 2007 Feb; 81(2):539-47. PubMed ID: 17062604
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death.
Norell H; Martins da Palma T; Lesher A; Kaur N; Mehrotra M; Naga OS; Spivey N; Olafimihan S; Chakraborty NG; Voelkel-Johnson C; Nishimura MI; Mukherji B; Mehrotra S
Cancer Res; 2009 Aug; 69(15):6282-9. PubMed ID: 19638595
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.
Chhabra A; Yang L; Wang P; Comin-Anduix B; Das R; Chakraborty NG; Ray S; Mehrotra S; Yang H; Hardee CL; Hollis R; Dorsky DI; Koya R; Kohn DB; Ribas A; Economou JS; Baltimore D; Mukherji B
J Immunol; 2008 Jul; 181(2):1063-70. PubMed ID: 18606658
[TBL] [Abstract][Full Text] [Related]
10. Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.
Kesarwani P; Chakraborty P; Gudi R; Chatterjee S; Scurti G; Toth K; Simms P; Husain M; Armeson K; Husain S; Garrett-Mayer E; Vasu C; Nishimura MI; Mehrotra S
Oncotarget; 2016 Oct; 7(43):69371-69383. PubMed ID: 27750220
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice.
Hu Z; Xia J; Fan W; Wargo J; Yang YG
Oncotarget; 2016 Feb; 7(6):6448-59. PubMed ID: 26824989
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
[TBL] [Abstract][Full Text] [Related]
13. MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Ray S; Chhabra A; Chakraborty NG; Hegde U; Dorsky DI; Chodon T; von Euw E; Comin-Anduix B; Koya RC; Ribas A; Economou JS; Rosenberg SA; Mukherji B;
Clin Immunol; 2010 Sep; 136(3):338-47. PubMed ID: 20547105
[TBL] [Abstract][Full Text] [Related]
14. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
15. Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs.
Anikeeva N; Panteleev S; Mazzanti NW; Terai M; Sato T; Sykulev Y
J Biol Chem; 2021 Sep; 297(3):101033. PubMed ID: 34371020
[TBL] [Abstract][Full Text] [Related]
16. Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering.
Sandalova E; Wei CH; Masucci MG; Levitsky V
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3011-6. PubMed ID: 14970329
[TBL] [Abstract][Full Text] [Related]
17. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack.
Seeger JM; Schmidt P; Brinkmann K; Hombach AA; Coutelle O; Zigrino P; Wagner-Stippich D; Mauch C; Abken H; Krönke M; Kashkar H
Cancer Res; 2010 Mar; 70(5):1825-34. PubMed ID: 20179203
[TBL] [Abstract][Full Text] [Related]
19. Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice.
Tabbekh M; Franciszkiewicz K; Haouas H; Lécluse Y; Benihoud K; Raman C; Mami-Chouaib F
J Immunol; 2011 Jul; 187(1):102-9. PubMed ID: 21622855
[TBL] [Abstract][Full Text] [Related]
20. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
Twu YC; Gold MR; Teh HS
Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
